Valeant Pharmaceuticals (VRX) Raises Offer for Obagi Medical (OMPI) to $24/Sh

April 3, 2013 8:04 AM EDT Send to a Friend
Obagi Medical Products, Inc. (NASDAQ: OMPI) today announced that Obagi and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) have executed an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login